Raul Parra Jr. - 27 Feb 2025 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)

Role
CFO AND TREASURER
Signature
/s/ Brian G. Lloyd, Attorney-in-Fact
Issuer symbol
MMSI
Transactions as of
27 Feb 2025
Net transactions value
-$2,048,720
Form type
4
Filing time
03 Mar 2025, 20:20:59 UTC
Previous filing
12 Nov 2024
Next filing
06 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MMSI Common Stock, No Par Value Award $0 +20,760 +127% $0.000000 37,121 27 Feb 2025 Direct F2
transaction MMSI Common Stock, No Par Value Tax liability $818,436 -8,309 -22% $98.50 28,812 27 Feb 2025 Direct F3
transaction MMSI Common Stock, No Par Value Award $0 +7,840 +27% $0.000000 36,652 28 Feb 2025 Direct F4
transaction MMSI Common Stock, No Par Value Sale $1,230,283 -12,451 -34% $98.81 24,201 28 Feb 2025 Direct F5
holding MMSI Common Stock, No Par Value 2,770 27 Feb 2025 By 401(k) Plan F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MMSI Non-qualified stock options (right to buy) 5,361 27 Feb 2025 Common Stock 5,361 $37.71 Direct F6
holding MMSI Non-qualified stock options (right to buy) 9,681 27 Feb 2025 Common Stock 9,681 $56.25 Direct F7
holding MMSI Non-qualified stock options (right to buy) 14,570 27 Feb 2025 Common Stock 14,570 $65.03 Direct F8
holding MMSI Non-qualified stock options (right to buy) 13,576 27 Feb 2025 Common Stock 13,576 $70.58 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents plan holdings as of 02/28/2025.
F2 These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02.28.2022.
F3 The Reporting Person surrendered 8,309 shares of common stock to the Issuer for payroll taxes. No shares were sold in the open market.
F4 Represents a grant of restricted stock units ("RSUs"). The RSUs vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.
F5 The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.09 to $99.345, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F6 Becomes exercisable in equal annual installments of 25% commencing 02/26/2021.
F7 Becomes exercisable in equal annual installments of 25% commencing on 03/19/2022.
F8 Becomes exercisable in equal annual installments of 25% commencing 02/28/2023.
F9 Becomes exercisable in equal annual installments of 25% commencing 02/28/2024.